AAVantgarde Bio

Description: AAVantgarde Bio develops gene therapies for inherited retinal disorders, spun out from Telethon Institute and backed by Sofinnova Partners.

Country: Italy

Based in: Milano

Founded: 2021

Funding Stage: Seed

Tags: ['Biotechnology', 'Therapeutics', 'Life Sciences']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.